To create an individualized cancer vaccine, researchers must identify cancer-specific peptides called neoantigens, then use a cell-, protein-, or nucleic acid–based platform to deliver those ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback